Henry Schein Inc. (HSIC)

Precedente Chiudi:

$68.60

Aprire:

$68.71

Volume 24 ore:

1.16M

Capitalizzazione di mercato:

$8.71B

Reddito:

$12.34B

Utile/perdita netta:

$416.00M

Rapporto P/E:

19.82

EPS:

3.42

Flusso di cassa netto:

$313.00M

1 W Prestazione:

-7.32%

1M Prestazione:

-7.71%

6M Prestazione:

+8.62%

1 anno Prestazione:

-15.29%

Intervallo 1D:

$67.64

$69.31

Portata 52W:

$60.01

$82.63

Henry Schein Inc. Stock (HSIC) Company Profile

Nome

Henry Schein Inc.

Settore

Healthcare (1221)

Industria

Medical Distribution (12)

Telefono

631-843-5500

Indirizzo

135 Duryea Road, Melville, NY

Dipendente

22,000

Cinguettio

@henryschein

Prossima data di guadagno

2024-05-14

Ultimi documenti SEC

HSIC's Discussions on Twitter

Henry Schein Inc. Stock (HSIC) Upgrades & Downgrades

Data	Azione	Analista	Modifica della valutazione
2023-12-12	Aggiornamento	JP Morgan	Neutral → Overweight
2023-11-10	Aggiornamento	Stifel	Hold → Buy
2022-08-08	Aggiornamento	UBS	Sell → Neutral
2022-07-21	Downgrade	Goldman	Buy → Neutral
2022-06-14	Downgrade	Robert W. Baird	Outperform → Neutral
2022-05-13	Ripresa	Credit Suisse	Outperform
2022-01-31	Iniziato	Morgan Stanley	Underweight
2022-01-07	Aggiornamento	Credit Suisse	Neutral → Outperform
2021-10-01	Ripresa	Credit Suisse	Neutral
2021-02-08	Ripresa	Piper Sandler	Overweight
2021-01-04	Aggiornamento	Robert W. Baird	Neutral → Outperform
2020-11-03	Aggiornamento	Barrington Research	Mkt Perform → Outperform
2020-05-06	Downgrade	Barrington Research	Outperform → Mkt Perform
2020-04-07	Aggiornamento	Goldman	Neutral → Buy
2020-04-02	Aggiornamento	Wolfe Research	Peer Perform → Outperform
2020-01-09	Downgrade	BofA/Merrill	Neutral → Underperform
2020-01-02	Aggiornamento	Evercore ISI	Underperform → In-line
2019-08-07	Downgrade	William Blair	Outperform → Mkt Perform
2019-05-30	Iniziato	Wolfe Research	Underperform
2019-05-15	Downgrade	SVB Leerink	Outperform → Mkt Perform
2019-04-18	Iniziato	Guggenheim	Buy
2019-01-17	Iniziato	UBS	Sell
2019-01-03	Downgrade	Evercore ISI	In-line → Underperform
2019-01-02	Downgrade	Robert W. Baird	Outperform → Neutral
2018-11-08	Reiterato	Barrington Research	Outperform
2018-10-25	Downgrade	Edward Jones	Hold → Sell
2018-10-19	Ripresa	Goldman	Neutral
2018-10-04	Reiterato	Robert W. Baird	Outperform
2018-08-07	Reiterato	Stifel	Hold
2018-04-24	Downgrade	Goldman	Buy → Neutral
2018-04-04	Aggiornamento	Leerink Partners	Mkt Perform → Outperform

Mostra tutto

Henry Schein Inc. Borsa (HSIC) Ultime notizie

West Pharmaceutical Services (WST) Tops Q1 Earnings and Revenue Estimates

Zacks Investment Research

Align Technology (ALGN) Surpasses Q1 Earnings and Revenue Estimates

Zacks Investment Research

Henry Schein (HSIC) Gears Up for Q1 Earnings: Factors to Note

Zacks Investment Research

Jack Daniels Parent Company, EA, Cognizant Among 6 Stocks That Shine When Nvidia Slips: Analysis

Benzinga

Henry Schein (HSIC) Global Presence Aids, Macroeconomic Woes Stay

Zacks Investment Research

Here's Why You Should Retain Henry Schein (HSIC) Stock for Now

Zacks Investment Research

Henry Schein Inc. Azioni (HSIC) Dati Finanziari

Henry Schein Inc. (HSIC) Reddito 2024

Henry Schein Inc. (HSIC) Reddito netto 2024

Henry Schein Inc. (HSIC) Flusso di cassa 2024

Henry Schein Inc. (HSIC) Utile per azione 2024

Henry Schein Inc. Azioni (HSIC) insider trading